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IMMUNE CHANGES IN HUMANS
CONCOMITANT WITH SPACE FLIGHTS OF
UP TO 10 DAYS DURATION
GERALD R. TAYLOR
NASA/L.B. Johnson Space Center, Houston, TX
Space flight offers an important tool to life sciences
researchers, while at the same time creating
operationally important problems requiring solution
for optimal crew safety and productivity. The time
relation of various classes of in-flight human
physiological changes may be illustrated with the
histogram shown in the figure 1.
As this figure shows, certain problems, such as
neurovestibular, fluid, and electrolyte imbalances
tend to occur early in a flight followed by stabilization
at some micro-gravity equilibration level.
Cardiovascular dysfunctions and erythrocyte mass
losses appear to follow a similar pattern, although the
significant changes occur later in flight. Bone and
calcium changes and radiation effects are thought to
progressively worsen with time, whereas the time
course of immune changes is yet to be fully
understood (1).
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Over the past 20 years we have documented
certain significant immunologic changes in
cosmonauts and astronauts during or after space
flight (2). Human immunologic changes reported
from a variety of U.S and Russian studies include
major depressions in the ability of blast cells to
transform in response to mitogenic challenge, a loss
of cytokine production or function, major changes in
peripheral or splenic immune cell populations,
alterations in natural killer cell activity and response to
colony stimulating factor, and depressions in the
delayed-type hypersensitivity response. The few
studies that have been conducted with the antibody-
mediated humoral immune system have been
inconclusive. Although occasional post flight
quantitative changes in immunoglobulin classes
have been reported, the ability to normally produce
specific antibodies in vivo in response to antigenic
challenge remains to be tested. Therefore, the
effect of space flight on the ability of the body to
produce antibodies remains unexplored.
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Microbiological changes have likewise been
documented (3). These have include a
"simplification" of crew autoflora, characterized by a
significant reduction of saprophites, with a relative
increase in the incidence of potentially pathogenic
microorganisms on body surfaces. In addition, there
has been a buildup of yeasts and filamentous fungi
within the space cabin, microbial contamination
between crew members, and increased
"pathogenicity" of certain species following space
flight.
The above information indicates that space flight
can be expected to effect a blunting of the human
cellular immune mechanism concomitant with a
relative increase in potentially pathogenic
microorganisms. This combination would seem to
increase the probability of infectious disease events
in flight (4). In fact, there was a very high in-flight
infectious disease incidence reported in the early
days of the U.S. space program before adoption of a
preflight health stabilization program. For example,
during the first seven flights of the Apollo program
illness events were not uncommon, with crew
members experiencing upper respiratory problems,
influenza, viral gastroenteritis, rhinitis, pharyngitis,
and mild dermatologic problems (5). Apollo 13 was
an esPeCially important mission from the infectious
disease point of view. First, one of the crew
members was removed from flight just days before
launch after being exposed to an active case of
measles. Second, an active Pseudomonas
aeruginosa urinary tract infection developed from the
latent state in one crew member. It will be
remembered that the Apollo 13 vehicle was partially
destroyed while traveling towards the moon and that
the remainder of the mission was characterized by
unusually high stress. Given what we know about
the blunting of immune capability during space flight
there is no doubt that stress exacerbated this
infection (6).
Preflight crew isolation was initiated following the
Apollo 13 mission and has continued in one form or
another as an integral part of the U.S. space program
(7). This procedure was designed to allow the
autoflora to equilibrate at a level consistent with
confinement and to allow contracted infectious
agents to demonstrate themselves before flight. It is
likely that this procedure contributed to the
significant reduction in microbial problems reported
to have occurred during, or immediately following
U.S. Space flights subsequent to Apollo 13. We do
not have reliable data to show the effect of space
flight on the immune system prior to Apollo 14,
before the preflight health stabilization program was
initiated. However, data collected subsequent to
Apollo 13 show certain changes in immunological
parameters, outlined below, that would be of greater
concern without the intervention of this effective
countermeasure.
Throughout the last decade the Russian and U.S.
space programs have followed somewhat different
paths as shown in figure 2. As these data reveal, the
U.S. manned-space program has emphasized flights
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of less than one month. In fact, except for those
associated with the three SKYLAB flights, all U.S.
astronauts have been in space for less than two
weeks at a time. However, the Russian manned
space program has incorporated many flights with
varying length up to a full year. Therefore, this paper
emphasizes immunological changes during "short-
duration" missions. The "long-duration" results have
been presented by Konstantinova et al (8).
CREWMEMBER FLIGHTS
UP TO 12 MONTHS DURATION
309 -- I I I _._
250 " 250
200 _ uaL_-O ST_'m-S 200
150 W RUSSIA 150
OPt% /z"
CREWMEMBER 20 : 20_
19 t- t5
t_9 _
I[ .|. ,,
1 2 3 4 5 6 7 8 9 10 11 12
FLIGHT DURATION (MONTHS)
Extensive comparisons of preflight and post flight
immunological parameters were conducted with the
first 41 U.S. Space Shuttle astronauts (9) as
summarized in table 1. In this table is shown the
number of times a particular assay resulted in a larger,
or a smaller, post flight value when compared with
the pre flight baseline for that individual.
Summary of Postflight Changes in Shuttle Crew
Peripheral Blood Cells a
Factor n NPI(b) NPD(C) APC(d)
Lymphocyte Number 41 9 31 -13.3
Lymphocyte Stimulation 41 5 36 -25.7
Neutrophil Number 41 40 1 +102.0
Eosinophil Percent 41 4 35 NA*
Pan T Lymphocyte 11 6 5 +1.6
Pan B Lymphocyte 11 4 7 +9.7
Pan Monocyte 11 3 7 -11.6
"T" Helper 11 8 3 +11.1
"T" Suppressor 11 5 5 -2.3
T4/T8 Ratio 11 7 4 +13.4
a From Taylor and Dardano (1986)
b Number of postflight increases
c Number of postflight decreases
d Average postflight change
* Eosinophil percent postflight change not a useful statistic
because the count is typically reduced from small number
preflight to zero postflight.
This study demonstrated unequivocally that the
absolute number of lymphocytes in the peripheral
circulation, the ability of these cells to respond to
mitogenic stimulation, and the number of
eosinophils in the peripheral circulation were typically
decreased after flight. Conversely, there was an
almost universal doubling of the absolute neutrophil
number. Often there was a major change in the
T4/T8 ratio, resulting from an increase in the Helper
lymphocyte population. Additional data from 11 crew
members, indicate a post flight decrease in
circulating monocytes and "B" lymphocytes. Further,
the reduced "T" lymphocyte blastogenesis was
shown to correlate with the decreased monocyte
count (9).
More recently, an additional group of 30 U.S.
Shuttle astronauts were evaluated using similar
methods (10). The results of this study are shown
on table 2. The resulting slide cell differential data
confirmed the customary granulocytic increase and
lymphocytic decrease within the peripheral
circulation post flight. However, contrary to previous
findings this study reported a 52 % increase in the
post flight monocyte population. This increase was
borne out by a significant (P<0.01) increase in
monocytes as derived from subset analysis of
isolated peripheral blood mononuclear cells extracts
as shown in table 2.
Effect of space flight on peripheral blood leukocytes of 30 U,S. Astronauts
Launch Launch Landing
Test mtnus 10 days minus 2 days Landtng day plus 3 days
Totat teukocytes 5500 ± 200 5600 ± 200 7000 ± 200" 5650 ± 200
Granulocytes 3200 ± t 16 3024 ± 112 4970 ± t 40" 3050 ± 112
Lymphocytes 2262±58 2240_+112 1689±70" 2128± 112
Monocytes 133 _+17 199 _+22 245 __28" 190 _+25
Monocytes (CD14 +) 13±1 12¢1 21±1" 13±1
T inducer (CO4+* Leu-8 +) 32 _+2 34 _+2 23 _+ 1* 31 _+2
T cytotoxic (CDS*, CDt lb-) 18 +1 16 +_1 12 +_.1"" 17 ± 2
T helper (CD4 +, Leu-8-) 5st 7±1 7±1 7_+1
T suppressor (CD8 +, CD 11b +) 3 _+t 3 _+1 3 ± 1 2 _+1
NK celts {CD16 ÷ or CD56 ÷) 0 ± 1 9 _+1 3 ± 1* 5 ± 1 *
B cells (CDf9 +) 7±1 6±1 6±1 7±1
After Meehans et al. 1992
Dam are mean ± SE of cells/ram 3 determined by slide whole blood differential
Data are mean :_ SE of the percentage of MNC which express specific cell-surface antigens
NK assay performed on f 0 _stronauts samples
°P <9.01 Landing versus I_:_ch minus 19 days and 3 days after landing.
* P <0.05 Landing day vers,_s launch minus 10 days, 2 days and 3 days after landing.
The authors of these data, Meehan et aL, have
indicated that the apparent discrepancy may be the
result of mission length. Crew members that
demonstrated a post flight increase in peripheral
blood monocytes were in space for 4 to 5 days (10).
Conversely, those showing a post flight decrease in
peripheral blood monocytes were in space for 6 to 8
days (9). These results suggest that the monocyte
population moves between compartments as the
mission progresses, up to 8 days. This progression
may in fact be preceded by related neuroendocrine
changes. Meehan et al. indicate that the noted
increase in monocytes is inconsistent with the
reported increase in glucocorticoids, since this
should be accompanied by a decrease in peripheral
blood monocytes. Likewise, the percentages of
insulin receptor-positive cells and IGF-I receptor-
positive cells did not increase following flight as
would be expected with increased monocytes.
Therefore, these researchers may have been
fortunate enough to sample the population between
a change in the neuroendocrine cause, and the
immune cell response. In addition to the very
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interesting monocyte findings, the data in this table
also indicate the expected post flight reduction in
the number of "T" inducer, "T" cytotoxic, and NK
cells within the peripheral circulation.
The post-flight studies outlined above are very
important because it is often operationally impossible
to collect data in any other way, and they have given
us important clues concerning immunological
changes resulting from space flight. However,
reliance on post flight analyses presents serious
problems with data interpretation. Most important is
the fact that the samples must be collected after the
stressful conditions associated with landing,
followed by some variable degree of reacclimation to
terrestrial conditions (11). Thus, one can not, in this
way, adequately separate in-flight from landing
conditions as affectors of noted changes to the
immune system. In addition, the length of time
elapsing between when the .space craft returns to
Earth, and when investigators have access to crew
members for sample collection or medical analysis
varies with each flight. This time lag problem was
somewhat alleviated with the advent of the U.S.
Space Shuttle program because the shuttle vehicles
optimally land on a pre-determined runway. From the
point of view of scientific return, this is a great
improvement over previous programs where the
actual landing could be many miles from the
anticipated site.
These post flight tests have typically been
conducted in vitro. Therefore, a determination of the
degree to which crew members were
immunocompromized required extrapolation. This is
no different than the situation one is typically
presented with in health care. However, it has made
statements about the clinical importance of the
noted immune changes more difficult to support.
In a very few cases, an attempt was made to solve
the problem of conducting tests on post-flight
samples by collecting samples in-flight and either
analyzing them post-flight or in-flight. In the case of
post-flight analysis, sample storage conditions were
found to be highly unpredictable and the results
were generally not of much use. The few times that
in-flight sample analyses were attempted
demonstrated that the response to analysis
conditions, especially cell culture, were greatly
different in flight (12).
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Only recently has the effect of spaceflight on the
ability of the human cell mediated immune (CMI)
system to function normally in vivo been tested in
flight as shown in figure 3.
The ability of U.S. Space Shuttle crew members to
mount a delayed-type hypersensitivity response was
evaluated, in flight (13) with the Merieux Multitest
Cell-Mediated Immunity (CMI) System. This system
consists of a plastic skin puncture device that
simultaneously injects seven different glycerinated
recall antigens and one glycerine control in a
standard pattern. Reactivity, reliability, repeatability,
and safety of the antigens and application technique
have previously been established through extensive
field evaluations (14). Concentrations were selected
such that each was the lowest possible which still
produced the maximal incidence of positive DTH
reaction in a representative population of normal
healthy adults. This procedure is highly compatible
to in flight testing because the incidence of large
reactions is reduced, thus allowing for application
sites to be placed only 20 mm apart. Also, by using a
"minimal" concentration of each antigen, the
sensitivity of the test for detecting hypoergy or
anergy is maximized. We have established that the
delayed-type hypersensitivity (DTH) response to
common recall antigens is a simple, yet effective
method for evaluating inflight-mediated hypoergy
(13).
INFLIGHT CHANGES IN DTH REACTIONS OF TEN
U.S SPACE SHUTTLE CREWMEMBERS
No. of Positive Reaction
_eactions Score !mm)
Subject Mission pFb IFC pFb IFc
Length
1 4 6 5 31.5 32.7
2 4 4 5 16.0 18.3
3 4 6 4 37.1 18.8
4 5 2 0 7.0 0.0
5 5 5 2 22.8 11.0
6 5 5 3 26.0 10.5
7 10 5 3 19.5 11.5
8 10 5 3 21.0 12.0
9 10 3 2 10.5 8.5
10 40 4 3 23.0 13.5
From Taylor and Dardano, 1986
a in days; b Preflight; c Inflight
The CMI mechanism was evaluated in ten
astronauts by measuring their in-flight DTH response
to the common recall antigens of Tetanus,
Diphtheria, Streptococcus, Proteus, old tuberculin,
Candida, and Trichophyton. The results obtained
from each of the 10 crew members are illustrated in
table 3. On all occasions except one (crew member
2) the cell-mediated immune system responded to
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fewer antigens in flight as compared to the preflight
response. It should be noted that crew member 2
was on the shortest flight tested. Crew member 4
was the only subject who demonstrated anergy
during space flight. This subject was aboard the 5-
day flight.
In-flight data were also analyzed according to the
total value, in mm, of the mean induration diameters
of all the positive reactions for a particular subject.
This is referred to as the reaction score. In all but two
cases (crew member I and 2) the reaction score was
decreased during flight. Again, these two subjects
that registered an increase were aboard the shortest
mission. These results demonstrate that hypoergy
was the least during the shortest (4 day) mission,
whereas the 5-day mission resulted in the greatest
change.
These data suggest that on day four of a Space
Shuttle mission the cell-mediated immune system is
measurably degraded and that between day 5 and
day 10 the depression maximizes and the CMI
mechanism begins to adjust to the new conditions.
These findings would tend to support the
previously-discussed monocyte data because
monocyte control also appears to change
considerably between day 4 and 5 of space flight.
This similarity of results is very useful for developing
an explanation of the mechanism of immune
depression early in the mission since cells of the
macrophage lineage are generally considered to be
the main antigen-presenting cells in the DTH
reaction.
In vivo T cell proliferation requires interferon gamma
(INF-g) and probably interleukin 1 (IL-1). In addition,
proper secretion, and activity of interleukin 2 (IL-2) is
necessary for feedback control between
lymphocytes. Significant decreases in interleukin
production (especially IL-2) and interferon (INF)
alpha/beta and gamma have been reported in
Cosmonauts as shown in table 4.
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Capacity for Interferon-Formation of Lymphocytes In the Peripheral Blood of
Cosmonauts after Short Flights on SalyuI 6 and Salyut 7 Orbital Stations
Orbital
Station
Salyut-6
Activity of IFN-(z, IU/ml*
Duration of Flight 30-45 Days Before One Day
Expedition (Days) Cosmonaut Flight After Flight
EP 4-1 8 1 48 6
2 32 8
EP 5-2 7 t 4 4
2 6 4
EP 1-1 8 1 80 10
2 10 tO
3 160 10
EP 1-2 8 1 80 40
2 40 40
Salyut-7
From: Konstantinova, 1988
These data show a decreased ability to elaborate
interferon alpha in blood collected post flight from 6
of 9 Russian Cosmonauts. In the future, a thorough
in-flight investigation of T-lymphocyte and monocyte
activity is essential to determining the degree to
which interleukins contribute to the identified cell-
mediated immune dysfunction. Such investigations
should include, but not be limited to:
[1] IL-1 mediated activities such as prostoglandin
production, activation of natural killer (NK) cells,
macrophages, and lymphocytes
[2] the balance between IL-2 receptor activity
and IL-2 production
[3] INF-gamma production by activated T
lymphocytes and NK cells.
Finally, in the future it will be important to analyze
the in flight immune system results both in light of
neuroendocrine data and reliable estimates of the
stress environment experienced by each crew
member. Only in this way can the influence upon the
immune system of microgravity-induced changes
throughout the body be determined.
REFERENCES
1. Nicogossian, A.D., 1989. Countermeasures to
space deconditioning. In: Space Physiology and
Medicine. Lea & Fabiger, Philadelphia
2. Taylor, G.R., 1987. Cell Anomalies Associated
With Spaceflight Conditions. Immunobioloev of
Proteins and PeDtides IV, Plenum Press, pp 259
3. Taylor, G.R., 1974. Space Microbiology, Annual
Review of Microbiology. 28:121-137
4. Wu, et aL in press, Clinical diagnostics for long-
duration space missions. J. Clin. Chem,
5. Hawkins, W.R., and J.F. Zieglschmid, 1975.
Clinical aspects of crew health, In: Biomedical
Results of Apollo, NASA SP-368, Washington, D.C.
6. Taylor, G.R., 1974. Recovery of Medically
Important Micro-organisms From Apollo Astronauts.
Aerospace Med. 45:824-828
7. Wolley, B.S., and G.W. McCollum, 1975. Flight
crew health stabilization program. In: Biomedical
Results of Apollo, NASA SP-368, Washington D.C.
8. Konstantinova, I.V., 1988. Manned space flights
and the immune system. Long-term flights. In: The
Immune System Under Extreme Conditions: Space
Immunology, Problemy Kosmicheskoy. 59:73-104.
9. Taylor, GR., L.S. Neale, and J.R. Dardano, 1986.
Immunological analyses of U.S. Space Shuttle
Crewmembers. Aviat. Space Environ. Meal. 57:213
10. Meehan, R.T., et aL, 1992. Alterations in hyman
mononuclear leukocytes following space flight.
Immunology 76:491
11. Meehan, R.T., 1987. Human mononuclear cells
in vitro activation in microgravity and post-spaceflight.
Adv. Exp. Med. Biol, 225:273-286.
12. Cogoli, A., and P. Tschopp, 1985. Lymphocyte
reactivity during spaceflight. Immunology Today, 6:1
13. Taylor, G.R., and R.P. Janney, 1992. In vivo
testing confirms a blunting of the human cell-
mediated immune mechanism during space flight. J.
51:129-132
14. Kinker, W.T., et aL 1979. The multi-test system:
A standardized approach toevaluation of delayed
hypersensitivity and cell-mediated immunity. Ann.
II_MJ.CLgy_.,43: 73-79.
